| 000 | 01404 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513073606.0 | ||
| 264 | 0 | _c19930913 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/0002-9149(93)91128-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerk, S I | |
| 245 | 0 | 0 |
_aEffect of intravenous nitroglycerin on heparin dosage requirements in coronary artery disease. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cAug 1993 |
||
| 300 |
_a393-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitroglycerin _xadministration & dosage |
| 650 | 0 | 4 | _aPartial Thromboplastin Time |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 700 | 1 | _aGrunwald, A | |
| 700 | 1 | _aPal, S | |
| 700 | 1 | _aBodenheimer, M M | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 72 _gno. 5 _gp. 393-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9149(93)91128-5 _zAvailable from publisher's website |
| 999 |
_c8351456 _d8351456 |
||